{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:40:35Z","timestamp":1793043635677,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T00:00:00Z","timestamp":1566259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["5U01HL105569"],"award-info":[{"award-number":["5U01HL105569"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL124099"],"award-info":[{"award-number":["HL124099"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12931-019-1164-1","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T10:03:16Z","timestamp":1566295396000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Compartmentalization of anti-oxidant and anti-inflammatory gene expression in current and former smokers with COPD"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4506-8549","authenticated-orcid":false,"given":"Venkataramana K.","family":"Sidhaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet T.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyce","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuladeep R.","family":"Sudini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard J.","family":"Criner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jed W.","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles S.","family":"Berenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh","family":"Thimmulappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Wise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,20]]},"reference":[{"issue":"4","key":"1164_CR1","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1183\/09031936.03.00040703","volume":"22","author":"PJ Barnes","year":"2003","unstructured":"Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22(4):672\u201388.","journal-title":"Eur Respir J"},{"issue":"1","key":"1164_CR2","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1378\/chest.12-2664","volume":"144","author":"PA Kirkham","year":"2013","unstructured":"Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144(1):266\u201373.","journal-title":"Chest."},{"issue":"3","key":"1164_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2165\/00151829-200504030-00003","volume":"4","author":"I Rahman","year":"2005","unstructured":"Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med. 2005;4(3):175\u2013200.","journal-title":"Treat Respir Med"},{"issue":"1","key":"1164_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1155\/2013\/509130","volume":"20","author":"SF van Eeden","year":"2013","unstructured":"van Eeden SF, Sin DD. Oxidative stress in chronic obstructive pulmonary disease: a lung and systemic process. Can Respir J. 2013;20(1):27\u20139.","journal-title":"Can Respir J"},{"issue":"2 Pt 1","key":"1164_CR5","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1164\/ajrccm.156.2.9611013","volume":"156","author":"JE Repine","year":"1997","unstructured":"Repine JE, Bast A, Lankhorst I. Oxidative stress in chronic obstructive pulmonary disease. Oxidative stress study group. Am J Respir Crit Care Med. 1997;156(2 Pt 1):341\u201357.","journal-title":"Am J Respir Crit Care Med"},{"key":"1164_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma Q. Role of nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013;53:401\u201326.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"2","key":"1164_CR7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1513\/pats.201201-009MS","volume":"9","author":"S Biswal","year":"2012","unstructured":"Biswal S, Thimmulappa RK, Harvey CJ. Experimental therapeutics of Nrf2 as a target for prevention of bacterial exacerbations in COPD. Proc Am Thorac Soc. 2012;9(2):47\u201351.","journal-title":"Proc Am Thorac Soc"},{"issue":"78","key":"1164_CR8","doi-asserted-by":"publisher","first-page":"78ra32","DOI":"10.1126\/scitranslmed.3002042","volume":"3","author":"C. J. Harvey","year":"2011","unstructured":"Harvey CJ, Thimmulappa RK, Sethi S, Kong X, Yarmus L, Brown RH, et al. Targeting Nrf2 signaling improves bacterial clearance by alveolar macrophages in patients with COPD and in a mouse model. Sci Transl Med. 2011;3(78):78ra32.","journal-title":"Science Translational Medicine"},{"issue":"10","key":"1164_CR9","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1086\/508428","volume":"194","author":"CS Berenson","year":"2006","unstructured":"Berenson CS, Garlipp MA, Grove LJ, Maloney J, Sethi S. Impaired phagocytosis of nontypeable Haemophilus influenzae by human alveolar macrophages in chronic obstructive pulmonary disease. J Infect Dis. 2006;194(10):1375\u201384.","journal-title":"J Infect Dis"},{"issue":"11","key":"1164_CR10","volume":"11","author":"RA Wise","year":"2016","unstructured":"Wise RA, Holbrook JT, Criner G, Sethi S, Rayapudi S, Sudini KR, et al. Lack of effect of Oral Sulforaphane administration on Nrf2 expression in COPD: a randomized, double-blind. Placebo Controlled Trial PloS one. 2016;11(11):e0163716.","journal-title":"Placebo Controlled Trial PloS one"},{"issue":"4","key":"1164_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods."},{"issue":"1\u20132","key":"1164_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.mrrev.2007.11.006","volume":"659","author":"WO Osburn","year":"2008","unstructured":"Osburn WO, Kensler TW. Nrf2 signaling: an adaptive response pathway for protection against environmental toxic insults. Mutat Res. 2008;659(1\u20132):31\u20139.","journal-title":"Mutat Res"},{"key":"1164_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.pharmtox.46.120604.141046","volume":"47","author":"TW Kensler","year":"2007","unstructured":"Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89\u2013116.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1164_CR14","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.freeradbiomed.2018.04.557","volume":"121","author":"J Yan","year":"2018","unstructured":"Yan J, Li J, Zhang L, Sun Y, Jiang J, Huang Y, et al. Nrf2 protects against acute lung injury and inflammation by modulating TLR4 and Akt signaling. Free Radic Biol Med. 2018;121:78\u201385.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1164_CR15","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1165\/rcmb.2010-0321OC","volume":"45","author":"AA Lugade","year":"2011","unstructured":"Lugade AA, Vethanayagam RR, Nasirikenari M, Bogner PN, Segal BH, Thanavala Y. Nrf2 regulates chronic lung inflammation and B-cell responses to nontypeable Haemophilus influenzae. Am J Respir Cell Mol Biol. 2011;45(3):557\u201365.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"6","key":"1164_CR16","doi-asserted-by":"publisher","first-page":"L888","DOI":"10.1152\/ajplung.90369.2008","volume":"296","author":"T Rangasamy","year":"2009","unstructured":"Rangasamy T, Misra V, Zhen L, Tankersley CG, Tuder RM, Biswal S. Cigarette smoke-induced emphysema in a\/J mice is associated with pulmonary oxidative stress, apoptosis of lung cells, and global alterations in gene expression. Am J Physiol Lung Cell Mol Physiol. 2009;296(6):L888\u2013900.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"1164_CR17","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1172\/JCI200421146","volume":"114","author":"T Rangasamy","year":"2004","unstructured":"Rangasamy T, Cho CY, Thimmulappa RK, Zhen L, Srisuma SS, Kensler TW, et al. Genetic ablation of Nrf2 enhances susceptibility to cigarette smoke-induced emphysema in mice. J Clin Invest. 2004;114(9):1248\u201359.","journal-title":"J Clin Invest"},{"issue":"8","key":"1164_CR18","first-page":"3299","volume":"61","author":"M McMahon","year":"2001","unstructured":"McMahon M, Itoh K, Yamamoto M, Chanas SA, Henderson CJ, McLellan LI, et al. The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res. 2001;61(8):3299\u2013307.","journal-title":"Cancer Res"},{"key":"1164_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1465-9921-10-111","volume":"10","author":"BJ Carolan","year":"2009","unstructured":"Carolan BJ, Harvey BG, Hackett NR, O'Connor TP, Cassano PA, Crystal RG. Disparate oxidant gene expression of airway epithelium compared to alveolar macrophages in smokers. Respir Res. 2009;10:111.","journal-title":"Respir Res"},{"issue":"7\u20138","key":"1164_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.2119\/molmed.2008.00130","volume":"15","author":"RH Hubner","year":"2009","unstructured":"Hubner RH, Schwartz JD, De Bishnu P, Ferris B, Omberg L, Mezey JG, et al. Coordinate control of expression of Nrf2-modulated genes in the human small airway epithelium is highly responsive to cigarette smoking. Mol Med. 2009;15(7\u20138):203\u201319.","journal-title":"Mol Med"},{"issue":"10","key":"1164_CR21","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1136\/thx.2007.091181","volume":"63","author":"D Goven","year":"2008","unstructured":"Goven D, Boutten A, Lecon-Malas V, Marchal-Somme J, Amara N, Crestani B, et al. Altered Nrf2\/Keap1-Bach1 equilibrium in pulmonary emphysema. Thorax. 2008;63(10):916\u201324.","journal-title":"Thorax."},{"issue":"3","key":"1164_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1517\/14728221003629750","volume":"14","author":"A Boutten","year":"2010","unstructured":"Boutten A, Goven D, Boczkowski J, Bonay M. Oxidative stress targets in pulmonary emphysema: focus on the Nrf2 pathway. Expert Opin Ther Targets. 2010;14(3):329\u201346.","journal-title":"Expert Opin Ther Targets"},{"issue":"12","key":"1164_CR23","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/rccm.201002-0294OC","volume":"182","author":"Y Strulovici-Barel","year":"2010","unstructured":"Strulovici-Barel Y, Omberg L, O'Mahony M, Gordon C, Hollmann C, Tilley AE, et al. Threshold of biologic responses of the small airway epithelium to low levels of tobacco smoke. Am J Respir Crit Care Med. 2010;182(12):1524\u201332.","journal-title":"Am J Respir Crit Care Med"},{"key":"1164_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12931-014-0094-1","volume":"15","author":"MS Walters","year":"2014","unstructured":"Walters MS, De BP, Salit J, Buro-Auriemma LJ, Wilson T, Rogalski AM, et al. Smoking accelerates aging of the small airway epithelium. Respir Res. 2014;15:94.","journal-title":"Respir Res"},{"issue":"8","key":"1164_CR25","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1136\/thoraxjnl-2013-203373","volume":"68","author":"SS Sohal","year":"2013","unstructured":"Sohal SS, Walters EH. Epithelial mesenchymal transition (EMT) in small airways of COPD patients. Thorax. 2013;68(8):783\u20134.","journal-title":"Thorax."},{"issue":"5","key":"1164_CR26","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1183\/09031936.00135814","volume":"45","author":"ST Gohy","year":"2015","unstructured":"Gohy ST, Hupin C, Fregimilicka C, Detry BR, Bouzin C, Gaide Chevronay H, et al. Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition. Eur Respir J. 2015;45(5):1258\u201372.","journal-title":"Eur Respir J"},{"key":"1164_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1465-9921-14-120","volume":"14","author":"SS Sohal","year":"2013","unstructured":"Sohal SS, Walters EH. Role of epithelial mesenchymal transition (EMT) in chronic obstructive pulmonary disease (COPD). Respir Res. 2013;14:120.","journal-title":"Respir Res"},{"issue":"5","key":"1164_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064833","volume":"8","author":"SS Sohal","year":"2013","unstructured":"Sohal SS, Reid D, Soltani A, Weston S, Muller HK, Wood-Baker R, et al. Changes in airway histone deacetylase2 in smokers and COPD with inhaled corticosteroids: a randomized controlled trial. PLoS One. 2013;8(5):e64833.","journal-title":"PLoS One"},{"issue":"1","key":"1164_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1164\/rccm.200509-1461OC","volume":"174","author":"CS Berenson","year":"2006","unstructured":"Berenson CS, Wrona CT, Grove LJ, Maloney J, Garlipp MA, Wallace PK, et al. Impaired alveolar macrophage response to Haemophilus antigens in chronic obstructive lung disease. Am J Respir Crit Care Med. 2006;174(1):31\u201340.","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl","key":"1164_CR30","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1513\/AnnalsATS.201305-123AW","volume":"10","author":"PS Hiemstra","year":"2013","unstructured":"Hiemstra PS. Altered macrophage function in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2013;10(Suppl):S180\u20135.","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"1164_CR31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1164\/rccm.201705-0903OC","volume":"198","author":"MA Bewley","year":"2018","unstructured":"Bewley MA, Budd RC, Ryan E, Cole J, Collini P, Marshall J, et al. Opsonic phagocytosis in chronic obstructive pulmonary disease is enhanced by Nrf2 agonists. Am J Respir Crit Care Med. 2018;198(6):739\u201350.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1164_CR32","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1165\/rcmb.2007-0424OC","volume":"39","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, Betsuyaku T, Ito Y, Nagai K, Nasuhara Y, Kaga K, et al. Down-regulated NF-E2-related factor 2 in pulmonary macrophages of aged smokers and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2008;39(6):673\u201382.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"1164_CR33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00125-003-1065-0","volume":"46","author":"MC Blatter-Garin","year":"2003","unstructured":"Blatter-Garin MC, Kalix B, De Pree S, James RW. Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1. Diabetologia. 2003;46(4):593\u20134.","journal-title":"Diabetologia."},{"issue":"4","key":"1164_CR34","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0006-291X(03)01504-3","volume":"308","author":"N Grosser","year":"2003","unstructured":"Grosser N, Abate A, Oberle S, Vreman HJ, Dennery PA, Becker JC, et al. Heme oxygenase-1 induction may explain the antioxidant profile of aspirin. Biochem Biophys Res Commun. 2003;308(4):956\u201360.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"1164_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1191\/096032701674627721","volume":"20","author":"I Durak","year":"2001","unstructured":"Durak I, Karaayvaz M, Cimen MY, Avci A, Cimen OB, Buyukkocak S, et al. Aspirin impairs antioxidant system and causes peroxidation in human erythrocytes and Guinea pig myocardial tissue. Hum Exp Toxicol. 2001;20(1):34\u20137.","journal-title":"Hum Exp Toxicol"},{"issue":"7","key":"1164_CR36","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/bph.14592","volume":"176","author":"MZ Huang","year":"2019","unstructured":"Huang MZ, Yang YJ, Liu XW, Qin Z, Li JY. Aspirin eugenol ester attenuates oxidative injury of vascular endothelial cells by regulating NOS and Nrf2 signalling pathways. Br J Pharmacol. 2019;176(7):906\u201318.","journal-title":"Br J Pharmacol"},{"issue":"7","key":"1164_CR37","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1097\/WNR.0000000000000969","volume":"29","author":"W Wei","year":"2018","unstructured":"Wei W, Shurui C, Zipeng Z, Hongliang D, Hongyu W, Yuanlong L, et al. Aspirin suppresses neuronal apoptosis, reduces tissue inflammation, and restrains astrocyte activation by activating the Nrf2\/HO-1 signaling pathway. Neuroreport. 2018;29(7):524\u201331.","journal-title":"Neuroreport."},{"issue":"7","key":"1164_CR38","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/jcmm.12812","volume":"20","author":"Z Jian","year":"2016","unstructured":"Jian Z, Tang L, Yi X, Liu B, Zhang Q, Zhu G, et al. Aspirin induces Nrf2-mediated transcriptional activation of haem oxygenase-1 in protection of human melanocytes from H2 O2 -induced oxidative stress. J Cell Mol Med. 2016;20(7):1307\u201318.","journal-title":"J Cell Mol Med"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1164-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1164-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1164-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T00:00:28Z","timestamp":1597795228000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1164-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1164"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1164-1","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"assertion":[{"value":"24 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The clinical trial was approved by the Institutional Review Board (IRB) at each center; participants signed consent statements approved by the local IRB. The institutional review committees were: IRB-FC at Johns Hopkins Bloomberg School of Public Health for the data coordinating center and central laboratories, and IRB-2 at Johns Hopkins Medicine, Medical Interventions Committee A1 at Temple University, and the Buffalo VA Medical Center IRB for the 3 clinical centers, respectively; The trial was conducted under an Investigational New Drug Exemption (#109233) and was registered at  (NCT01335971). This report adheres to Consolidated Standards of Reporting Clinical Trials (CONSORT) guidelines for clinical trials (S1 CONSORT Checklist). The study is registered on  and data from the trial have been deposited in the BioLINCC repository (). Informed concent was obtained for every patient enrolled and the details are described in the trial manuscript.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"190"}}